Dangerous and common drug interactions in patients with diabetes mellitus

Endocrinology and Metabolism Clinics of North America

Volumn 29, Issue 4, 2000, Pages 789-801

  White, John R ^a   Campbell, R Keith ^b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CISAPRIDE; CORTICOSTEROID; CYTOCHROME P450; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EPHEDRINE; ESTROGEN DERIVATIVE; ETHINYLESTRADIOL; GLIMEPIRIDE; GLUCOSE; INDOMETACIN; LEVONORGESTREL; NICOTINIC ACID; ORAL ANTIDIABETIC AGENT; PENTAMIDINE; PHENYLBUTAZONE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PIROXICAM; PSEUDOEPHEDRINE; SALICYLIC ACID; SULFONYLUREA DERIVATIVE; UNINDEXED DRUG; WARFARIN;

CLINICAL TRIAL; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DRUG CROSS REACTIVITY; DRUG MECHANISM; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INSULIN TREATMENT; PRIORITY JOURNAL; REVIEW; SEXUAL DYSFUNCTION; STOMACH PARESIS;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-ANTAGONISTS; BLOOD GLUCOSE; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIURETICS; DRUG INTERACTIONS; ENZYME INHIBITORS; ETHANOL; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; SYMPATHOMIMETICS;

EID: 0034547995     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(05)70164-X     Document Type: Article

References (56)

1. Glucose intolerance during diuretic therapy: Results of trial by the European Working Party on Hypertension in the Elderly
2. Timolol topically and diabetes mellitus
3. Irreversible hypoglycemia: A complication of alcohol and insulin
4. Salicylates as hypoglycemia agents
5. Incidence of adverse drug events and potential adverse drug events: Implications for prevention
6. The costs of adverse drug events in hospitalized patients
7. Diabetes mellitus following pentamidine-induced hypoglycemia in humans
8. Drugs and diabetes
9. Drug-induced disorders of glucose metabolism
10. Identifying and managing patients with hyperlipidemia
11. Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality
12. The relevance of glucose counterregulatory systems to patients with insulin-dependent diabetes mellitus
13. Hyperosmolar nonketotic diabetic syndrome precipitated by treatment with diuretics
14. The effect of postmenopausal estrogen therapy on the risk of non-insulin-dependent diabetes mellitus
15. Management of dyslipidemia in IDDM patients
16. Dyslipidemias in diabetic patients: Is standard cholesterol treatment appropriate?
17. Oral hypoglycemic agents
18. GI stimulants: Cisapride
19. Short-term effect of red wine (consumed during meals) on insulin requirement and glucose tolerance in diabetic patients
20. Glucocorticoids and the risk for initiation of hypoglycemic therapy
21. Effects of long-term estrogen replacement therapy
22. Danger at the drugstore
23. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium
24. Adverse effects of antihypertensive drug therapy on glucose intolerance
25. Clinical management of hyperlipidemia in diabetic patients
26. Drug-related morbidity and mortality: A cost-of-illness model
27. Clinically significant drug interactions: What you need to know before writing prescriptions
28. Diabetes mellitus
29. Neonatal adrenergic blockade following single dose maternal labetalol administration
30. Effect of cardioselective and nonselective β-blockage on the hypoglycemic response in insulin-dependent diabetes
31. The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man
32. Systems analysis of adverse drug events
33. Effect of cold remedies on metabolic control of NIDDM
34. Deterioration of glucose tolerance in hypertensive patients on prolonged diuretic treatment
35. Management of dyslipidemia in adults with diabetes
36. A prospective study of postmenopausal estrogen therapy and subsequent incidence of non-insulin-dependent diabetes mellitus
37. Alcohol and diabetes
38. Propranolol, hypoglycemia, and hypertensive crisis
39. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
40. The P450 gene superfamily: Recommended nomenclature
41. Effects of drugs on glucose tolerance in non-insulin-dependent diabetes I
42. Effects of drugs on glucose tolerance in non-insulin-dependent diabetics II
43. Diabetic hypertensive patients: Is this a group in need of particular care and attention?
44. Type II diabetes mellitus and oral hypoglycemic agents
45. Hyperosmolar nonketotic diabetes mellitus associated with metolazone
46. Hypoglycemia-induced hypertension in a diabetic patient on metoprolol
47. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
48. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
49. Excess mortality associated with diuretic therapy in diabetes mellitus
50. Drug interactions in diabetic patients: The risk of losing glycemic control
51. Effect of duration of low-dose oral contraceptive administration on carbohydrate metabolism
52. Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism